C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2004
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481679A1 Antidepressant
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480966A1 Compounds and methods of treating cell proliferative diseases
12/01/2004	EP1480958A1 Uracil-thioether
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480950A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms i, viii and ix
12/01/2004	EP1480944A2 Substituted aryl ketones
12/01/2004	EP1480943A2 Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids
12/01/2004	EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004	EP1156037B1 Chondrongenesis promotors and indolin-2-one derivatives
12/01/2004	EP1104407B1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551876A 6-aryl-4-aminopicolinates and their use as herbicides
12/01/2004	CN1551870A Heterocyclic amide derivative and use as pesticide
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177825C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004	US6825230 Spiro and dispiro 1,2,4-trixolane antimalarials
11/30/2004	US6825220 3-Substituted oxindole β 3 agonists
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825215 1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-α
11/30/2004	US6825213 β3-adrenoreceptor agonists, agonist compositions and methods of using
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/30/2004	CA2075189C Method and compositions for the synthesis of bch-189 and related compounds
11/25/2004	WO2004101570A1 Sulfur-containing naphthoylimide derivatives
11/25/2004	WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004	WO2004101550A1 Oxetane compounds containing maleimide functionality
11/25/2004	WO2004101546A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/25/2004	WO2004101544A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	WO2004101533A1 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
11/25/2004	WO2004101528A2 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	WO2004101520A1 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists
11/25/2004	WO2004101519A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101514A1 Cyanofluoropyrrolidine derivative
11/25/2004	WO2004101506A1 Glyoxalase inhibitors
11/25/2004	WO2004100998A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/25/2004	WO2004100952A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opioid receptors ligands
11/25/2004	WO2004100946A1 1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) -piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or tnf inhibitors for the treatment of imflammations
11/25/2004	WO2004100881A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004	WO2004100865A2 New benzimidazole derivatives
11/25/2004	WO2004085385A3 Cannabinoid receptor ligands
11/25/2004	WO2004067489A3 Hydroxyl compounds and compositions for cholesterol management and related uses
11/25/2004	WO2004062609A3 Pyrimidine derivatives as il-8 receptor antagonists
11/25/2004	WO2004054498A3 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
11/25/2004	US20040236114 1-[(hetero)aryloxy- or -thio-hydroxyalkyl]-substituted imidazole-4-carboxamides, e.g., 1-(5-(1,1'-biphenyl-3-yloxy)-2-hydroxy-3-pentyl]imidazole-4-carboxamide; treating rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, sunburn, eczema, conjunctivitis, asthma, & bronchitis
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040235927 Synthesis and antimicrobial activity of novel dicationic "reversed amidines"
11/25/2004	US20040235926 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
11/25/2004	US20040235921 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist
11/25/2004	US20040235905 preventing overload of Ca2+ ions in cells; ischemic heart diseases, ischemic cerebral diseases, ischemic renal diseases and in the protection of cells during thrombolytic therapy, angioplasty, bypass operation of coronary artery or organ transplantation and arrhythmias
11/25/2004	US20040235902 Fluorescent probes for zinc
11/25/2004	US20040235897 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235891 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders
11/25/2004	US20040235888 Utilities of amide compounds
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235869 For therapy of subject infected with a retrovirus
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235852 Benzofuran inhibitors of factor VIIa
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235843 For therapy of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
11/25/2004	US20040235836 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/25/2004	US20040235829 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/25/2004	US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235798 Identifying a small organic molecule having a core structure, the small organic molecule having a cytotoxic antifungal activity; andpreparing a compound comprising the core structure of the identified cytotoxic antifungal agent
11/25/2004	US20040235723 Introducing ABC protein gene into yeast cell having high drug sensitivity to prepare transformed cell where protein is expressed in cell membrane, incubating cell in presence of test substance and substance which is subjected to active transfer outside cell by ABC protein in cell membrane, comparing
11/25/2004	US20040234957 Compositions and methods for labeling oligonucleotides
11/25/2004	US20040234884 Basic compound, resist composition and patterning process
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	CA2525858A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2525438A1 Glyoxalase inhibitors
11/25/2004	CA2524958A1 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	CA2524470A1 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004	CA2524434A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	CA2523431A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/24/2004	EP1479670A1 Novel fused ring indazole compounds
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative

1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 694